Page last updated: 2024-11-05

cyclopentamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Cyclopentamine is a synthetic sympathomimetic amine that acts as a direct-acting, non-selective adrenergic agonist. It was initially developed as a nasal decongestant and was marketed under the trade name Clopane. However, due to concerns about its potential for cardiovascular side effects, its use has been largely discontinued in many countries. Research on cyclopentamine has primarily focused on its pharmacological properties and potential therapeutic applications. Studies have investigated its effects on blood pressure, heart rate, and respiratory function. Cyclopentamine's potential for treating conditions like nasal congestion, hypotension, and asthma has been explored, although its use in these areas remains limited. The compound's mechanism of action involves stimulating both alpha and beta adrenergic receptors, resulting in vasoconstriction, bronchodilation, and increased heart rate. Further research is needed to fully understand cyclopentamine's therapeutic potential and to assess its safety profile. Its synthesis involves a multi-step process that typically begins with the reaction of cyclopentanone with an appropriate amine, followed by a series of chemical transformations.'

cyclopentamine: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID7608
CHEMBL ID329203
CHEBI ID134766
SCHEMBL ID249708
MeSH IDM0061245

Synonyms (54)

Synonym
clopane
CHEMBL329203
cyklosal
PDSP2_001086
PDSP1_001102
cyclopentamin
ethylamine, 2-cyclopentyl-n,1-dimethyl-
2-cyclopentyl-n,1-dimethylethylamine
cyclonarol
cyclopentamine (pharmacetical)
sinos
cyklosan
n,alpha-dimethylcyclopentaneethylamine
brn 2689148
cyclopentaminum [inn-latin]
cyclopentamine
cyclopentaneethanamine, n,alpha-dimethyl-
cyclopentadrin
ciclopentamina [inn-spanish]
cyclopentaneethanamine, n,.alpha.-dimethyl-
cyclopentaneethylamine, n,.alpha.-dimethyl-
cyclopentamine (inn)
D07370
102-45-4
CHEBI:134766
1-cyclopentyl-n-methylpropan-2-amine
bdbm81456
cas_7608
nsc_7608
AKOS011894854
ciclopentamina
cyclopentamine [inn]
unii-wb9q6m8o60
cyclopentamine [inn:ban]
4-12-00-00137 (beilstein handbook reference)
cyclopentaneethylamine, n,alpha-dimethyl-
cyclopentaminum
wb9q6m8o60 ,
cyclopentamine [mi]
n,.alpha.-dimethylcyclopentaneethylamine
(+/-)-cyclopentamine
cyclopentamine [who-dd]
cyclopentaneethanamine, n-.alpha.-dimethyl-
SCHEMBL249708
1-cyclopentyl-n-methyl-2-propanamine #
cyclopentadrine
clopane; cyclonarol; cyclopentadrin; cyclopentadrine; cyclopentamin
DB08999
(1-cyclopentylpropan-2-yl)(methyl)amine
Q15408414
DTXSID60861710
NCGC00510944-01
D84278
mfcd00864151

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
secondary amino compoundA compound formally derived from ammonia by replacing two hydrogen atoms by organyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID227700Anticonvulsant activity2003Bioorganic & medicinal chemistry letters, Aug-18, Volume: 13, Issue:16
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (75.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.84

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.84 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index47.56 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.84)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]